A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT) - Noble, S I; Nelson, A; Fitzmaurice, D (Health Technol Assess, 2015)
, 1–93